4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors
Open Access
- 1 September 1996
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (37) , 22441-22446
- https://doi.org/10.1074/jbc.271.37.22441
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Can Fenretinide Protect Women Against Ovarian Cancer?JNCI Journal of the National Cancer Institute, 1995
- Vertebrate receptors: molecular biology, dimerization and response elementsSeminars in Cell Biology, 1994
- Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR)Cancer Letters, 1994
- Retinoids Selective for Retinoid X Receptor Response PathwaysScience, 1992
- Homodimer formation of retinoid X receptor induced by 9-cis retinoic acidNature, 1992
- Activity of 4-HPR in superficial bladder caner using DNA flow cytometry as an intermediate endpointJournal of Cellular Biochemistry, 1992
- Differential effects of retinoids on pokeweed mitogen induced B-cell proliferation vs immunoglobulin synthesisInternational Journal of Immunopharmacology, 1991
- Long-term tolerability of fenretinide (4-HPR) in breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarinoma-III cells in Lobund-Wistar ratsCancer Letters, 1991
- Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancerCancer Letters, 1989